# Phase II Trial of Allovectin-7® for Metastatic Melanoma

> **NCT00044356** · PHASE2 · COMPLETED · sponsor: **Vical** · enrollment: 133 (actual)

## Conditions studied

- Melanoma
- Metastatic Melanoma
- Malignant Melanoma
- Skin Cancer

## Interventions

- **GENETIC:** Allovectin-7®

## Key facts

- **NCT ID:** NCT00044356
- **Lead sponsor:** Vical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2004-08
- **Final completion:** 2004-09
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00044356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00044356, "Phase II Trial of Allovectin-7® for Metastatic Melanoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00044356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*